The standard T/CMEAS 012-2023, titled "Risk Management Specifications for High Alert Medications in Healthcare Institutions," was published on January 1, 2023. This document provides comprehensive guidelines and best practices for healthcare institutions to effectively manage high alert medications (HAMs). HAMs are drugs that if misused or administered incorrectly can cause severe harm or death to patients. The standard aims at minimizing the risk of medication errors through a systematic approach that includes identification, assessment, prevention, and monitoring of potential hazards associated with these critical medications.
Adopting this normative document, healthcare providers are encouraged to establish robust policies and procedures for handling HAMs across all levels of patient care. It underscores the importance of continuous education and training for medical staff on safe practices concerning these high-risk drugs. Additionally, the standard emphasizes the need for technological interventions such as barcoding systems, automated dispensing machines, and electronic prescribing tools to further enhance safety measures in medication management.
The implementation of T/CMEAS 012-2023 is expected to significantly improve patient outcomes by reducing adverse drug events linked to HAMs. By adhering to the risk management framework outlined in this standard, healthcare institutions can better protect patients from the dangers posed by high alert medications while promoting a culture of safety within their organizations.
*** Please note: This description may not be accurate, please refer to the official documentation.
Copyright ©2025 All Rights Reserved